To assess the targeted effect of the CSC vaccine on elimination of CD44+CD117+CSCs, we investigated the CD44+CD117+double positive cell population in ovarian cancer tissues from the vaccinated mice. The gene discussed is KIT; the disease is ovarian carcinoma.